Title : In silico prediction of mozenavir as a potential drug for SARS-CoV-2 infection via binding multiple drug targets.

Pub. Date : 2022 Feb

PMID : 34690521






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Through molecular docking and dynamic simulation studies, we used the FDA-approved drug mezonavir against the most important viral targets, including spike (S) glycoprotein, Transmembrane serine protease 2 (TMPRSS2), RNA-dependent RNA polymerase (RdRp), Main protease (Mpro), human angiotensin-converting enzyme 2 (ACE-2), and furin. mezonavir transmembrane serine protease 2 Homo sapiens
2 Through molecular docking and dynamic simulation studies, we used the FDA-approved drug mezonavir against the most important viral targets, including spike (S) glycoprotein, Transmembrane serine protease 2 (TMPRSS2), RNA-dependent RNA polymerase (RdRp), Main protease (Mpro), human angiotensin-converting enzyme 2 (ACE-2), and furin. mezonavir transmembrane serine protease 2 Homo sapiens